Leading organizations unite to affirm vaccine safety amid rising misinformation and declining trust
Business Announcement
Updates every hour. Last Updated: 13-May-2025 21:09 ET (14-May-2025 01:09 GMT/UTC)
In response to growing concerns over vaccine misinformation, declining public trust in science, and recent outbreaks of preventable diseases, a coalition of [x] scientific and medical organizations, led by the American Association of Immunologists (AAI) and the American College of Physicians (ACP), has issued a unified statement emphasizing the critical role of vaccinations in public health.
The incidence of babies born with serious heart defects, known as cyanotic congenital heart disease (CCHD), rose in states that enacted restrictive abortion laws following the U.S. Supreme Court’s 2022 ruling that put abortion laws in the hands of the states, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.25).
Lifestyle and health factors that are linked with heart disease appear to have a greater impact on cardiovascular risk in women than men, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.25).
Climate change is not just an environmental issue — it’s a mental health crisis impacting on adolescent wellbeing right now in areas most affected by climate change, according to new research from Trinity College Dublin.
Conducted by CNRS researchers1, an unprecedented study on the combined use of sunscreen and an insect repellent that is among the best selling in France during summer concludes that UV2 protection decreases after application of the mixture. With the spread of tiger mosquitoes in many countries, it has become increasingly common for people to combine these two products during outdoor activities3 to protect themselves from both the sun and these pests. This is the first paper that studies the effects of such a mixture. It has just appeared in Parasites and Vectors.
New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse. This should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required.